celecoxib has been researched along with Vascular Diseases in 2 studies
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib was unable to prevent oxaliplatin-related vascular pain in this study." | 9.30 | Randomized phase II trial of the prophylactic use of celecoxib for the prevention of oxaliplatin-related peripheral vascular pain in Capeox (YCOG1205). ( Endo, I; Ishibe, A; Momiyama, M; Nagamine, K; Ota, M; Saigusa, Y; Saito, S; Suwa, H; Suwa, Y; Suzuki, S; Watanabe, J; Watanabe, K; Yamanaka, T, 2019) |
| "Celecoxib was unable to prevent oxaliplatin-related vascular pain in this study." | 5.30 | Randomized phase II trial of the prophylactic use of celecoxib for the prevention of oxaliplatin-related peripheral vascular pain in Capeox (YCOG1205). ( Endo, I; Ishibe, A; Momiyama, M; Nagamine, K; Ota, M; Saigusa, Y; Saito, S; Suwa, H; Suwa, Y; Suzuki, S; Watanabe, J; Watanabe, K; Yamanaka, T, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suwa, Y | 1 |
| Watanabe, J | 1 |
| Ota, M | 1 |
| Suzuki, S | 1 |
| Suwa, H | 1 |
| Watanabe, K | 1 |
| Saito, S | 1 |
| Nagamine, K | 1 |
| Momiyama, M | 1 |
| Ishibe, A | 1 |
| Saigusa, Y | 1 |
| Yamanaka, T | 1 |
| Endo, I | 1 |
| Taddei, S | 1 |
| Caraccio, N | 1 |
| Virdis, A | 1 |
| Dardano, A | 1 |
| Versari, D | 1 |
| Ghiadoni, L | 1 |
| Ferrannini, E | 1 |
| Salvetti, A | 1 |
| Monzani, F | 1 |
2 trials available for celecoxib and Vascular Diseases
| Article | Year |
|---|---|
Randomized phase II trial of the prophylactic use of celecoxib for the prevention of oxaliplatin-related peripheral vascular pain in Capeox (YCOG1205).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Celecoxib; Chemotherapy, Adjuvan | 2019 |
Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis.
Topics: Acetylcholine; Adult; Algorithms; Ascorbic Acid; Celecoxib; Cyclooxygenase 2; Endothelium, Vascular; | 2006 |